To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Jim Greenwood, CEO of the Biotechnology Innovation Organization, responds to the passage of H.R. 3.
This video helps break down the experience of a senior in the Medicare Part D program.
The following video has the answer and it may surprise you.